NEW YORK (GenomeWeb News) – DioGenix announced today a collaboration with Fast Forward to develop a molecular diagnostic test for multiple sclerosis.

As part of the deal, Fast Forward, a subsidiary of the National Multiple Sclerosis Society, will provide DioGenix $500,000 to expand its ongoing clinical trial for MSPrecise, a diagnostic test based on next-generation sequencing to measure genetic mutations in the adaptive immune system by analyzing B cells isolated from cerebral spinal fluid.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

In Science this week: environmental DNA can help in studies of marine animals, and more.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.